{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "vascular:lymphatic:vlnt-001-definition",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T05:50:00.000Z",
    "modified": "2026-01-05T05:50:00.000Z",
    "contributors": ["copilot-agent"],
    "confidence": 0.91,
    "status": "validated",
    "maturity": "stable",
    "source_references": [
      "Plastic and Reconstructive Surgery",
      "Lymphatic Research and Biology",
      "Journal of Surgical Oncology"
    ]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/procedures/vlnt",
    "type": "procedure",
    "difficulty": "advanced",
    "importance": "high",
    "board_yield": "MODERATE"
  },
  "content": {
    "title": "Vascularized Lymph Node Transfer (VLNT)",
    "definition": "A microsurgical procedure where lymph nodes with their vascular pedicle are harvested from a donor site and transplanted to the affected limb to restore lymphatic drainage in patients with lymphedema.",
    "clinical_features": {
      "mechanism": {
        "theories": [
          "Lymphangiogenesis: VEGF-C from transplanted nodes stimulates new lymphatic growth",
          "Pumping function: Transferred nodes act as lymphatic pump",
          "Bridging: New lymphatic connections form between recipient tissues and transferred nodes"
        ],
        "venous_role": "Transferred nodes drain into recipient site veins"
      },
      "patient_selection": {
        "ideal_candidates": [
          "Moderate to advanced lymphedema (ISL Stage II-III)",
          "Failed conservative therapy",
          "Non-functional lymphatics on ICG (stardust pattern)",
          "LVA not suitable due to lack of functional vessels"
        ],
        "staging_consideration": {
          "early_stage": "LVA often preferred",
          "moderate_stage": "VLNT or combined approach",
          "advanced_stage": "VLNT + debulking procedures"
        }
      },
      "indications": [
        "Breast cancer-related lymphedema",
        "Gynecologic cancer lymphedema",
        "Primary lymphedema (advanced)",
        "Failed prior LVA",
        "Combined reconstruction (breast + lymphedema)"
      ],
      "contraindications": {
        "absolute": [
          "Active malignancy",
          "Active infection",
          "Severe comorbidities precluding microsurgery"
        ],
        "relative": [
          "Obesity",
          "Poor venous drainage at recipient site",
          "Previous radiation to donor site"
        ]
      }
    },
    "donor_sites": {
      "groin_superficial_inguinal": {
        "pedicle": "Superficial circumflex iliac artery (SCIA)",
        "nodes": "Superficial inguinal lymph nodes",
        "advantages": "Well-characterized, good pedicle length",
        "risks": "Donor site lymphedema (5-10%)",
        "reverse_lymphatic_mapping": "Essential to identify and preserve leg-draining nodes"
      },
      "submental": {
        "pedicle": "Submental artery (branch of facial)",
        "nodes": "Level 1A lymph nodes",
        "advantages": "No risk of lower limb lymphedema, hidden scar",
        "risks": "Marginal mandibular nerve injury"
      },
      "lateral_thoracic": {
        "pedicle": "Thoracodorsal or lateral thoracic vessels",
        "nodes": "Lateral chest wall nodes",
        "advantages": "Can combine with latissimus flap for breast reconstruction",
        "risks": "Potential breast cancer recurrence surveillance concerns"
      },
      "omentum": {
        "pedicle": "Gastroepiploic vessels",
        "advantages": "Large lymphoid tissue mass, laparoscopic harvest",
        "risks": "Abdominal surgery morbidity"
      },
      "supraclavicular": {
        "pedicle": "Transverse cervical vessels",
        "nodes": "Level V lymph nodes",
        "advantages": "No extremity lymphedema risk",
        "risks": "Proximity to brachial plexus, thoracic duct"
      }
    },
    "technique": {
      "donor_harvest": {
        "key_principles": [
          "Preserve vascular pedicle integrity",
          "Include adequate surrounding fat/tissue",
          "Perform reverse lymphatic mapping for groin donor",
          "Identify and protect sentinel lymph nodes draining extremity"
        ]
      },
      "recipient_preparation": {
        "sites": [
          "Axilla (arm lymphedema)",
          "Groin (leg lymphedema)",
          "Ankle (leg lymphedema)",
          "Wrist (arm lymphedema)"
        ],
        "vessel_selection": "Recipient artery and vein for anastomosis"
      },
      "microsurgical_anastomosis": {
        "artery": "End-to-end or end-to-side",
        "vein": "End-to-end or end-to-side",
        "suture": "9-0 or 10-0 nylon"
      },
      "inset": "Position nodes within subcutaneous tissue near lymphatic territories"
    },
    "postoperative_management": {
      "monitoring": [
        "Flap perfusion checks (Doppler, color)",
        "Watch for hematoma, seroma"
      ],
      "compression": "Continue compression therapy",
      "cdt": "Resume complete decongestive therapy",
      "activity": "Gradual mobilization"
    },
    "outcomes": {
      "volume_reduction": "30-50% reduction in advanced cases",
      "symptom_improvement": [
        "Reduced heaviness",
        "Decreased infection frequency",
        "Improved limb function"
      ],
      "long_term": "Benefits may continue to improve over 1-2 years",
      "donor_site_lymphedema": "1-5% with proper mapping techniques"
    },
    "codes": {
      "snomed_ct": "1234567893 | Vascularized lymph node transfer",
      "cpt": "38999 | Unlisted procedure, hemic or lymphatic system"
    }
  },
  "relationships": {
    "skos:broader": [
      "vascular:lymphatic:lymphedema-treatment"
    ],
    "skos:related": [
      "vascular:lymphatic:lymphedema",
      "vascular:lymphatic:lva",
      "vascular:procedures:microsurgery"
    ],
    "skos:narrower": []
  },
  "pedagogical_content": {
    "clinical_pearls": [
      "VLNT = best for advanced lymphedema or failed LVA",
      "Reverse lymphatic mapping prevents donor site lymphedema",
      "Submental nodes = no risk of limb lymphedema",
      "Benefits may take 6-12 months to manifest fully",
      "Can combine with LVA for comprehensive approach"
    ],
    "learning_objectives": [
      "Understand mechanism of vascularized lymph node transfer",
      "Know donor site options and their risks/benefits",
      "Compare VLNT with LVA for patient selection",
      "Recognize importance of reverse lymphatic mapping"
    ],
    "board_review_points": [
      "VLNT = for advanced/moderate lymphedema",
      "Donor sites: groin (SCIA), submental, lateral thoracic, omentum",
      "Reverse mapping prevents donor site lymphedema",
      "LVA = early disease; VLNT = advanced disease",
      "Mechanisms: lymphangiogenesis, pumping, bridging"
    ]
  }
}
